9 research outputs found

    SARS-COV-2 variants: epidemiology, pathophysiology and the importance of vaccines

    Get PDF
    El SARS-CoV-2 es un virus ARN monocatenario de la familia de los coronavirus, causante de la COVID-19 (Coronavirus Disease 2019). Este virus es responsable de la pandemia actual que, desde su apariciĂłn a finales de 2019, ha provocado la muerte de millones de personas y ha tenido un impacto global no solo a nivel sanitario sino tambiĂ©n econĂłmico y social. Por ello, el presente artĂ­culo tiene como objetivo revisar la informaciĂłn mĂĄs actualizada sobre el SARS-CoV-2, empezando por describir los mecanismos de transmisiĂłn del virus, su fisiopatologĂ­a y filogenĂ©tica. Asimismo, presentarĂĄ a las variantes emergentes del SARS-CoV-2, su relevancia para la salud pĂșblica local y global, su epidemiologĂ­a en PerĂș, y finalmente, el rol y la importancia de las vacunas en este contexto.SARS-CoV-2 is a single-stranded RNA virus of the coronavirus family, which causes COVID-19 (Coronavirus Disease 2019). This virus is responsible for the current pandemic, which, since its emergence in late 2019, has caused millions of deaths and has had a global impact not only on public health but also on social and economic areas. Therefore, this article aims to review the most up-to-date information on SARS-CoV-2, beginning with the description of the pathophysiology and phylogenetics of the virus. Also, we will present the emerging SARS-CoV-2 variants, their relevance for local and global public health, their epidemiology in Peru, and finally, the role and importance of vaccines in this context

    A systematic review of population and patient perspectives and experiences as measured in Latin American and Caribbean surveys

    Full text link
    High-quality health systems must provide accessible, people-centred care to both improve health and maintain population trust in health services. Furthermore, accurate measurement of population perspectives is vital to hold health systems accountable and to inform improvement efforts. To describe the current state of such measures in Latin America and the Caribbean (LAC), we conducted a systematic review of facility and population-based assessments that included patient-reported experience and satisfaction measures. Five databases were searched for publications on quantitative surveys assessing healthcare quality in Spanish-or Portuguese-speaking LAC countries, focusing on the domains of processes of care and quality impacts. We included articles published since 2011 with a national sampling frame or inclusion of multiple subnational regions. We tabulated and described these articles, identifying, classifying and summarizing the items used to assess healthcare quality into the domains mentioned earlier. Of the 5584 publications reviewed, 58 articles met our inclusion criteria. Most studies were cross-sectional (95%), assessed all levels of healthcare (57%) and were secondary analyses of existing surveys (86%). The articles yielded 33 unique surveys spanning 12 LAC countries; only eight of them are regularly administered surveys. The most common quality domains assessed were satisfaction (in 33 out of 58 articles, 57%), evidence-based/effective care (34%), waiting times (33%), clear communication (33%) and ease of use (31%). Items and reported ratings varied widely among instruments used, time points and geographical settings. Assessment of patient-reported quality measures through population-and facility-based surveys is present but heterogeneous in LAC countries. Satisfaction was measured frequently, although its use in accountability or informing quality improvement is limited. Measurement of healthcare quality in LAC needs to be more systematic, regular, comprehensive and to be led collaboratively by researchers, governments and policymakers to enable comparison of results across countries and to effectively inform policy implementation.Fil: Medina Ranilla, JesĂșs. Universidad Peruana Cayetano Heredia;Fil: Espinoza, Laura AngĂ©lica. Universidad Peruana Cayetano Heredia;Fil: Mazzoni, Agustina. Instituto de Efectividad ClĂ­nica y Sanitaria; ArgentinaFil: Roberti, Javier Eugenio. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Parque Centenario. Centro de Investigaciones en EpidemiologĂ­a y Salud PĂșblica. Instituto de Efectividad ClĂ­nica y Sanitaria. Centro de Investigaciones en EpidemiologĂ­a y Salud PĂșblica; ArgentinaFil: Garcia Elorrio, Ezequiel. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Oficina de CoordinaciĂłn Administrativa Parque Centenario. Centro de Investigaciones en EpidemiologĂ­a y Salud PĂșblica. Instituto de Efectividad ClĂ­nica y Sanitaria. Centro de Investigaciones en EpidemiologĂ­a y Salud PĂșblica; ArgentinaFil: Leslie, Hannah Hogan. University of California; Estados UnidosFil: GarcĂ­a, Patricia Jannet. Universidad Peruana Cayetano Heredia

    Health system quality and COVID-19 vaccination: a cross-sectional analysis in 14 countries.

    Get PDF
    The social and behavioural determinants of COVID-19 vaccination have been described previously. However, little is known about how vaccinated people use and rate their health system. We used surveys conducted in 14 countries to study the health system correlates of COVID-19 vaccination. Country-specific logistic regression models were adjusted for respondent age, education, income, chronic illness, history of COVID-19, urban residence, and minority ethnic, racial, or linguistic group. Estimates were summarised across countries using random effects meta-analysis. Vaccination coverage with at least two or three doses ranged from 29% in India to 85% in Peru. Greater health-care use, having a regular and high-quality provider, and receiving other preventive health services were positively associated with vaccination. Confidence in the health system and government also increased the odds of vaccination. By contrast, having unmet health-care needs or experiencing discrimination or a medical mistake decreased the odds of vaccination. Associations between health system predictors and vaccination tended to be stronger in high-income countries and in countries with the most COVID-19-related deaths. Access to quality health systems might affect vaccine decisions. Building strong primary care systems and ensuring a baseline level of quality that is affordable for all should be central to pandemic preparedness strategies
    corecore